Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Research data from GlaxoSmithKline update understanding of cervical cancer
June 12th, 2008
In this recently published article, scientists in Rixensart, Belgium conducted a study "To evaluate and compare treatment patterns and related resource use and costs in women with abnormal cervical smears in five countries. Data from patient charts were collected for a minimum of 24 months, starting from the first recorded abnormal cervical smear." "Costs, from the public health perspective, were calculated based on country-specific unit costs per procedure and expressed in euros. A total of 3,380 patient charts were reviewed. Subjects with suspected or detectable cervical cancer were excluded from the analysis (n = 380). A significant age difference of 1.8-2.6 years...
Source: Women's Health Weekly (2008-06-12)
|
